Olympus Corporation- Company Profile

Company overview

OLYMPUS CORPORATION, a Japan-based manufacturer, mainly manufactures and sells medical products, life and industrial products, imaging products, information communication products and other products. The Company operates in five business segments.

• The Medical segment is engaged in the manufacture and sale of medical endoscopes, surgical endoscopes, endoscope disposal equipment and ultrasonic endoscopes.
• The Life and Industrial segment provides biological microscopes, industrial microscopes, endoscopes for industrial use and non-destructive testing equipment.
• The Imaging segment is engaged in the manufacture and sale of digital cameras and voice recorders.
• The Information Communication segment is engaged in the sale of mobile terminals, such as cellular phones.
• The Others segment is engaged in the development of biomaterials and systems, industrial endoscopes, nondestructive inspection equipment, printers, mobile solutions and mobile contents services, the development and sale of package software, the sale of semiconductor-related equipment and electronic machines, as well as the development of systems.

In August 2009, the Company disposed its analytical equipment business to its wholly owned subsidiary, which has been engaged in the manufacturing and sale of clinical laboratory examination equipment. In addition, the Company has sold the subsidiary to Beckman Coulter, Inc. on August 1, 2009. As a result, the Company holds no stake in the subsidiary.
As of March 31, 2011, the Company has 188 subsidiaries and 11 associated companies.

Key Facts

Type	Public Company
Company Size	34,391 employees
Website	www.olympus-global.com
Founded	1919
Headquarters	Tokyo, Japan
Regional involvement	Worldwide
Employees	34,391
Chairman & CEO	Tsuyoshi Kikukawa
President & COO	Michael C. Woodford

Key Financials

Olympus Corporation
Financial Year End	March, 31st
Revenue	2011: ¥847.10B / $10.58B
	2010: ¥ 883.08B / $11.03B
Revenue Change	-4.07%
Operating Income	2011: ¥35.4 B / $442M
	2010: ¥60.1B / $751M
Operating Income Change	-41.10%
Net Profit	2011: ¥7.38B / $92.25M
	2010: ¥47.76B / $597M
Net Profit Change	-84.45%
R&D Expenses	2011: ¥67.28B / $841M
	2010: ¥61.85B / $773M

Revenue Distribution

Source: SEC fillings

Business Overview

Business lines

The company operates under the following business lines:

Organisation Structure

Medical Systems Business

The Medical Systems Business covers gastrointestinal endoscopes, surgical endoscopes, endotherapy devices, endoscopic ultrasound systems and medical information systems.
With an approximately 70% share, the Olympus group has secured a leading position in the global Gastrointestinal endoscopy market. Working to expand diagnostic coverage beyond the digestive system, the group is developing new equipment and new techniques ranging from diagnosis through treatment.
It's current research focus is on both minimally invasive treatment technology that reduces the burden on patients and product usability, for example, enhanced performance and functions to benefit doctors and technicians. The group's flagship products are equipped with a high-resolution endoscopic system and Narrow Band Imaging technology so that they can also support cancer diagnosis and treatment.

Medical systems business has the following business lines:

• Endoscopes
  Endoscopic video imaging systems, medical information systems, fiberscope systems, broncho endoscope systems, endoscopic ultrasound systems; ultrasound fiberscopes; ultrasound probes; ultrasound centers; ultrasound-guided needle puncture systems; cleaning, disinfecting and sterilization systems; medical treatment peripherals; ancillary products
• Endosurgery
  Endoscopy products for gastroenterological surgery, thoracic surgery, urology, gynecology, orthopedic surgery, neurosurgery, cardiovascular surgery, anesthesiology and otolaryngology; treatment and surgical equipment; peripherals
• Endotherapy
  Endotherapy products

Revenue

Source: SEC fillings
* MIP includes surgical endoscopes and treatment equipments.

• Medical systems segment has over 14,000 employees

Projections for FY 2012

Quarter 3

• In endoscopes, new shipments of some products (Lucera) have ground to a halt, but the company expects to see a rebound in 2H. For the year as a whole it projects endoscope sales will be down 5% YoY.
• The company estimates 1H sales in the medical systems division at JPY165bn (-6% YoY), and OP at JPY27bn; it projects 2H sales at JPY195bn (+8%) and OP at JPY43bn.
• In the medical systems division, new product launches are planned for both surgical endoscopes and energy devices (treatment tools).
• It projects sales of MIPs (surgical endoscopes, treatment equipment) at JPY180.5bn (+10% YoY). Sales in FY3/11 were flat YoY due mainly to the strength of the yen, but positive growth is expected this year.
• The company projects sales of gastrointestinal endoscopes at JPY164bn, -5% YoY, reflecting production setbacks in 1H.
• The earthquake’s impact has caused bottlenecks in purchasing of parts and materials for gastrointestinal endoscopes,leading to delays in product launches. In the latest telephone conference, the company offered no new information about timing. We believe there has been no real change from the company’s comments at the results briefing in May,and it remains to be seen whether the company will be able to launch its new products this fiscal year. The company’s FY3/12 earnings forecasts do not reflect any contribution from new products. Sales in the medical systems division got off to a slow start, falling short of projections in April-May.

Endoscopes Business

Market Share

Source: Espicom

The worldwide endoscopy market (comprising laparoscopy, gastro-intestinal, visualisation, arthroscopy and urology products, rigid and flexible scopes, implants, surgical and other instruments) was worth approximately US$21.3 billion in 2009. Olympus’ share of this market was estimated to be 18%($3.834B), behind market leader Johnson & Johnson with an approximate 21% market share. In third place was Covidien (13%), followed by Boston Scientific (7%), Stryker (4%), Smith & Nephew (4%) and Karl Storz (4%).

Product Portfolio

Olympus

In the medical equipment market, growth in the inspection device field has been stagnant, although such therapeutic device fields as surgical and endotherapy devices have shown market growth and drawn attention for technological innovation.

• The Exera 2, the previous entry in the Exera series, used NBI technology to enable full-color endoscopy, allowing doctors to more easily recognize affected areas in their patients. This product thus addressed doctors’ needs in the area of visibility, and sales grew worldwide.

Recent Developments

S.No.	Date	News/Development
1.	1st July 2011	Olympus Corporation to Acquire Spirus Medical, Inc., an endoscope insertion device manufacturer
2.	26th May 2011	Narrow Band Imaging (NBI) endoscopic technology, useful in early cancer detection, selected for the Prime Minister Prize at the 2011 National Commendation for Invention
3.	24th May 2011	Olympus ScopeGuide Receives FDA Clearance
4.	6th April 2011	Olympus Names Luke Calcraft as President of Medical Systems Group in the Americas
5.	10th February 2011	Olympus Names Michael C. Woodford to Serve as President
6.	25th October 2010	Magnetically guided capsule endoscope system presented at UEGW in Barcelona
7.	26th May 2010	Olympus Develops World’s Fastest, Most Compatible Endoscope Reprocessor
8.	30th April 2010	Olympus Medical Systems Corporation and Siemens Healthcare announce collaborative development of advanced magnetically guided capsule endoscope system for intragastric observation
9.	12th April 2010	Olympus Medical Systems India Private Limited established, would take care of Sales, marketing and service for medical equipment (endoscopes and related products, and surgical products, etc.)
10.	24th February 2010	Olympus Introduces HDTV Gastroscope with Auxiliary Water Channel
11.	10th November 2009	Olympus Introduces World's Smallest GI Scope to Offer 4-Way Angulation and Narrow Band Imaging
12.	23rd October 2009	Improved Endo Capsule Software Enhances Diagnostic Experience
13.	16th February 2009	Olympus Introduces World’s First Combined Endoscopic Ultrasound Processor for Imaging and Treatment of Digestive and Pulmonary Diseases
14.	11th December 2008	Olympus further enhances credentials by entering into exclusive sales and distribution partnership with market and technology leader Advanced Surgical Concepts
15.	17th November 2008	Olympus Medical Systems Europa and BrainLAB Sign Sales and Marketing Cooperation Agreement

Gastrointestinal Endoscopes Business

With an approximately 70% global market share for gastrointestinal endoscopes and an established position at the medical vanguard, Olympus maintains its passion for advancing technologies in response to doctors' needs

Diagnosis and Treatment using Gastrointestinal Endoscopy

Diagnosis

• Biopsy
• Cytodiagnosis
• Staining

Treatment

• Cancer (esophageal, stomach, colon, etc.)
• Varcies (esophageal)
• Foreign object retrieval ( esophagus, stomach)
• Hemostasis (stomach)
• Ployps (stomach, colon)
• Gallstones, bile duct stenosis (duodenum)

Market Share

Source: Espicom

Company ( in Billion Yen)	2009	2010	2011
Olympus	212.89	191.94	195.45
FujiFilm HD	26.98	25.00	27.00
Hoya	48.87	47.00	45.00

Products Offered

Speciality	Details	Picture	Products
Gastroscopy	Endoscopic examination, therapy or surgery of the interior of the stomach.		GIF-H180J: Enables one to perform upper gastrointestinal endoscopy utilising the latest auxiliary water function and the sharpest possible image quality provided by High-resolution HDTV images featuring Narrow Band Imaging™ (NBI) and Close Focus GIF-H180: Delivers the best possible image quality for upper GI. High-resolution HDTV images in combination with Narrow Band Imaging (NBI) and Close Focus functionality GIF-XP180N: Ultra-slim upper gastrointestinal endoscopy with four-way angulation, NBI compatibility and a 5.5mm diameter distal end and insertion tube GIF-Q180: Features a short bending section as well as a reduced bending radius. Manoeuvrability and observation especially in the cardia region are enhanced. GIF-N180: The entire insertion tube measures just 4.9mm in diameter, resulting in improved insertability and the option for transnasal insertion in nearly 100 % of cases. GIF-Q165: Clear, sharp high-quality images in a large-size display and slim, 9.2 mm diameter distal end insertion tuber with wide 140° feild of view GIF-2T160: Two-channel endoscope for a variety of therapeutic applications GIF-XTQ160: Endoscope with powerful suction capabilities GIF-1TQ160: Endoscope with extended instrumentation capabilities GIF-Q160Z: Powerful 115 times magnification for detailed examination of the mucous surface
Duodenoscopy	Endoscopic examination, therapy or surgery of the luminal surface of the duodenum		TJFQ180V: Provides critical visual feedback to enhance clinical decision making. In addition, a completely redesigned forceps elevator offers doctors the control needed when locking various sizes of guidewire. The unique dual locking function sets a new standard for ease-of-use and security during instrument exchange. TJF-160VR: Innovative V Groove forcep elevator offers reliable duodenoscopic treatment capability in combination with dedicated V-System ERCP devices TJF-145: Excellent treatment capability with extra-large 4.2mm channel - perfect for a wide range of endo-therapy accessories including stents. JF-140R: Facilitates introduction and manipulation of EndoTherapy accessories (for example papillotomes and ERCP catheters). The removable distal cap makes it possible to have access to all sides of the forceps elevator which can consequently be easily and quickly cleaned.
Colonoscopy	Endoscopic examination, therapy or surgery of the luminal surface of the colon.		CF-H180AI/L: High-resolution HDTV images combined with the widest field of view ever available in a colonoscope: 170° lets you look even behind the folds potentially decreasing the miss-rate and improving orientation inside the colon. CF-Q180AI/L: The widest field of view ever available in a colonoscope: 170° lets you look even behind the folds potentially decreasing the miss-rate and improving orientation inside the colon. CF-Q160DI/L: ScopeGuide is a new Olympus product, which displays the shape and position of a colonoscope in real time throughout the examination without the use of x-rays. It based on magnetic fields generated by small coils build inside this endoscope and picked up by the antenna of ScopeGuide's main unit. From this data, the computer reconstructs a schematic picture of endoscope on the display. PCF-H180AI/L: Extra-slim colonoscope featuring outstanding high-resolution HDTV imaging and adjustable insertion characteristics CF-Q165I/L: Versatile colonoscope combining high image quality, large-size display and powerful treatment capability. CF-1T140I/L: For use in both therapeutic procedures and routine examinations, offers “graduated flexibility” for ease of insertion, and greater operational control and torque transmission to the distal end. CF-2T160I/L: Two-channel therapeutic capabilities CF-Q160ZI/L: Precision design that enables lens movement fully controlled via a connected magnification controller, which also provides foot switch operation. Powerful 150 times zoom magnification delivers detailed close-ups
Proctoscopy	Endoscopic examination, therapy or surgery of the luminal surface of the rectum.		Rectal Diagnostic System: a complete line-up of instruments for rectoscopy, which have been especially designed for the diagnosis of possible disorders in the rectal region. Highest functionality combined with long-term durability distinguishes these instruments at reasonable investment costs. Transanal Endoscopic Microsurgery System: a versatile line up of transparent tubes enable clear inspection of the affected area. Access to a lesion is made easier by a "side window sheath". Fully compatible with standard VISERA equipment.
Enteroscopy	Endoscopy of the small intestines accomplished while advancing the endoscope into the intestines from the stomach		QuickClip2 Hemostatic Clip: Rotatable function provides better targeting capability . It's 9 mm clip opening is ideal for targeting lesions in the tight confines of the small bowel Injector Force Max Injection Needle: Kink-resistant sheath improves procedure efficiency and limits the occurrence of kinking in the depths of the small bowel. BiCOAG: Bipolar spiral tip allows effective coagulation at virtually any angle and centrally located flushing port allows for easy irrigation PolyLoop Ligating Loop: Proprietary ligating loop for prophylactic hemostasis Biopsy Forceps: Specially designed to minimize damage to the enteroscope with it's stainless steel construction.

Source: Company website

New Products

• Evis Lucera Colono-Videoscope: It helps in reducing the burden on patients and improving performance for both the inspection and treatment of colorectal cancer through the incorporation of two new functions, namely, high flexibility and highly responsive control at the insertion site, while adopting a thinner scope.
• Evis Lucera Gastrointestinal Videoscope: This slim gastrointestinal videoscope can be inserted through the nasal tract or the mouth to realise high quality images and is suited for the examination of lesions in the upper digestive tract, for example, in the stomach.
• Capsule Endoscopes:
  
  
  They are non-invasive, endoscopic imaging by use of VIDEO CAPSULE ENDOSCOPES to perform examination of the gastrointestinal tract, especially the small bowel. After being introduced in 2007, they have become a revolution. High-resolution imaging, real-time viewing, ease of use and proprietary hard and software make EndoCapsule a comprehensive and powerful system - redefining capsule endoscopy.
  One has to simply swallow the Endo capsule, a pill sized (11mm in external diameter and 26mm in length) capsule equipped with a tiny camera and lights, allows pictures to be taken of the entire small bowel. Endo capsule delivers high resolution images equivalent to those provided by endoscopes. EndoCapsule displays a clear and bright field of view for the fine observation of a variety of small bowel abnormalities.
  The Real Time Viewer enables the physician to test the proper functionality before the procedure and to confirm the location of the capsule in the GI tract during the process. In addition it is now possible to check whether and when the capsule has left the stomach.
  Product Details:
  
  • Supersensitive CCD
  • Ultra compact lens
  • Automatic Brightness Control adjusts illumination to maintain optimal imaging
  • A wide depth of field provides superior observation
  • 6 white LED lights always ensure a clear field of view
  • Compact battery with energy efficient technology

The company is developing technologies to expand the application of capsule endoscopes to the stomach and large bowel.
Source: Company website, SEC fillings